adenine has been researched along with Disseminated Fungal Infection in 17 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "We describe the opportunistic infections occurring in 362 patients with lymphoproliferative disorders treated with ibrutinib and idelalisib in clinical practice." | 4.02 | Infections in patients with lymphoproliferative diseases treated with targeted agents: SEIFEM multicentric retrospective study. ( Busca, A; Candoni, A; Cattaneo, C; Dargenio, M; Facchinelli, D; Fanci, R; Farina, F; Laurenti, L; Lessi, F; Marchesi, F; Marchesini, G; Nadali, G; Pagano, L; Picardi, M; Prezioso, L; Spolzino, A; Tisi, MC; Trastulli, F; Verga, L; Visentin, A, 2021) |
| "Invasive bacterial infections developed in 23 (53." | 1.48 | Serious Infections in Patients Receiving Ibrutinib for Treatment of Lymphoid Cancer. ( Cohen, N; Hohl, TM; Palomba, ML; Redelman-Sidi, G; Seo, SK; Taur, Y; Varughese, T, 2018) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 9 (52.94) | 24.3611 |
| 2020's | 8 (47.06) | 2.80 |
| Authors | Studies |
|---|---|
| Gold, JAW | 1 |
| Tolu, SS | 1 |
| Chiller, T | 1 |
| Benedict, K | 1 |
| Jackson, BR | 1 |
| Asawa, P | 1 |
| Chahine, Z | 1 |
| Vusqa, U | 1 |
| Samhouri, Y | 1 |
| Fazal, S | 1 |
| Egger, M | 1 |
| Gornicec, M | 1 |
| Wölfler, A | 1 |
| Lembeck, AL | 1 |
| Tinchon, C | 1 |
| Maderdonner, M | 1 |
| Prattes, J | 1 |
| Booth, E | 1 |
| Backx, M | 1 |
| Joshi, A | 1 |
| Nizami, H | 1 |
| Elmusharaf, N | 1 |
| Ruchlemer, R | 1 |
| Ben-Ami, R | 1 |
| Bar-Meir, M | 1 |
| Brown, JR | 1 |
| Malphettes, M | 1 |
| Mous, R | 1 |
| Tonino, SH | 1 |
| Soussain, C | 1 |
| Barzic, N | 1 |
| Messina, JA | 1 |
| Jain, P | 1 |
| Cohen, R | 1 |
| Hill, B | 1 |
| Mulligan, SP | 1 |
| Nijland, M | 1 |
| Herishanu, Y | 1 |
| Benjamini, O | 1 |
| Tadmor, T | 1 |
| Okamoto, K | 1 |
| Arthurs, B | 1 |
| Gottesman, B | 1 |
| Kater, AP | 1 |
| Talha, M | 1 |
| Eichhorst, B | 1 |
| Korem, M | 1 |
| Bogot, N | 1 |
| De Boer, F | 1 |
| Rowe, JM | 1 |
| Lachish, T | 1 |
| Maffei, R | 1 |
| Maccaferri, M | 1 |
| Arletti, L | 1 |
| Fiorcari, S | 1 |
| Benatti, S | 1 |
| Potenza, L | 1 |
| Luppi, M | 1 |
| Marasca, R | 1 |
| Reynolds, G | 1 |
| Slavin, M | 1 |
| Teh, BW | 1 |
| Marchesini, G | 1 |
| Nadali, G | 1 |
| Facchinelli, D | 1 |
| Candoni, A | 1 |
| Cattaneo, C | 1 |
| Laurenti, L | 1 |
| Fanci, R | 1 |
| Farina, F | 1 |
| Lessi, F | 1 |
| Visentin, A | 1 |
| Marchesi, F | 1 |
| Prezioso, L | 1 |
| Spolzino, A | 1 |
| Tisi, MC | 1 |
| Trastulli, F | 1 |
| Picardi, M | 1 |
| Verga, L | 1 |
| Dargenio, M | 1 |
| Busca, A | 1 |
| Pagano, L | 1 |
| Holowka, T | 1 |
| Cheung, H | 1 |
| Malinis, M | 1 |
| Gan, G | 1 |
| Deng, Y | 1 |
| Perreault, S | 1 |
| Isufi, I | 1 |
| Azar, MM | 1 |
| Chamilos, G | 2 |
| Lionakis, MS | 2 |
| Kontoyiannis, DP | 2 |
| Serota, DP | 1 |
| Mehta, AK | 1 |
| Phadke, VK | 1 |
| Bazaz, R | 1 |
| Denning, DW | 1 |
| Varughese, T | 1 |
| Taur, Y | 1 |
| Cohen, N | 1 |
| Palomba, ML | 1 |
| Seo, SK | 1 |
| Hohl, TM | 1 |
| Redelman-Sidi, G | 1 |
| Cummins, KC | 1 |
| Cheng, MP | 2 |
| Kubiak, DW | 1 |
| Davids, MS | 1 |
| Marty, FM | 1 |
| Issa, NC | 2 |
| Kusztos, AE | 1 |
| Gustine, JN | 1 |
| Dryden-Peterson, SL | 1 |
| Dubeau, TE | 1 |
| Woolley, AE | 1 |
| Hammond, SP | 1 |
| Baden, LR | 1 |
| Treon, SP | 1 |
| Castillo, JJ | 1 |
| Grossi, O | 1 |
| Pineau, S | 1 |
| Sadot-Lebouvier, S | 1 |
| Hay, B | 1 |
| Delaunay, J | 1 |
| Miailhe, AF | 1 |
| Bretonnière, C | 1 |
| Jeddi, F | 1 |
| Lavergne, RA | 1 |
| Le Pape, P | 1 |
1 review available for adenine and Disseminated Fungal Infection
| Article | Year |
|---|---|
Immunomodulatory effect of ibrutinib: Reducing the barrier against fungal infections.
Topics: Adenine; Agammaglobulinaemia Tyrosine Kinase; Humans; Invasive Fungal Infections; Leukemia, Lymphocy | 2020 |
16 other studies available for adenine and Disseminated Fungal Infection
| Article | Year |
|---|---|
Incidence of Invasive Fungal Infections in Patients Initiating Ibrutinib and Other Small Molecule Kinase Inhibitors-United States, July 2016-June 2019.
Topics: Adenine; Humans; Incidence; Invasive Fungal Infections; Piperidines; United States | 2022 |
Invasive Aspergillosis of the Spleen in the setting of Ibrutinib use.
Topics: Adenine; Aspergillosis; Humans; Invasive Fungal Infections; Piperidines; Spleen | 2022 |
Incidence of invasive fungal infections in patients with hematological malignancies receiving ibrutinib therapy in south-east Austria.
Topics: Adenine; Animals; Antifungal Agents; Austria; Hematologic Neoplasms; Humans; Incidence; Invasive Fun | 2022 |
Disseminated invasive aspergillosis in a patient treated with ibrutinib for chronic lymphocytic leukaemia.
Topics: Adenine; Aspergillosis; Humans; Invasive Fungal Infections; Leukemia, Lymphocytic, Chronic, B-Cell; | 2023 |
Ibrutinib-associated invasive fungal diseases in patients with chronic lymphocytic leukaemia and non-Hodgkin lymphoma: An observational study.
Topics: Adenine; Adult; Aged; Aged, 80 and over; Female; Humans; Immunocompromised Host; Invasive Fungal Inf | 2019 |
Ibrutinib and invasive fungal infections: the known, the unknown and the known unknowns.
Topics: Adenine; Humans; Incidence; Invasive Fungal Infections; Leukemia, Lymphocytic, Chronic, B-Cell; Myco | 2020 |
Infections in patients with lymphoproliferative diseases treated with targeted agents: SEIFEM multicentric retrospective study.
Topics: Adenine; Agammaglobulinaemia Tyrosine Kinase; Aged; Aged, 80 and over; Bacterial Infections; Case-Co | 2021 |
Incidence and associated risk factors for invasive fungal infections and other serious infections in patients on ibrutinib.
Topics: Adenine; Aged; Humans; Incidence; Invasive Fungal Infections; Leukemia, Lymphocytic, Chronic, B-Cell | 2021 |
Call for Action: Invasive Fungal Infections Associated With Ibrutinib and Other Small Molecule Kinase Inhibitors Targeting Immune Signaling Pathways.
Topics: Adenine; Aged; Aged, 80 and over; Female; Fungi; Hematologic Neoplasms; Humans; Immunosuppressive Ag | 2018 |
Invasive Fungal Sinusitis due to Mucor Species in a Patient on Ibrutinib.
Topics: Adenine; Humans; Invasive Fungal Infections; Mucor; Piperidines; Pyrazoles; Pyrimidines; Signal Tran | 2018 |
Reply to Bazaz and Denning.
Topics: Adenine; Animals; Invasive Fungal Infections; Piperidines; Pyrazoles; Pyrimidines; Signal Transducti | 2018 |
Subacute Invasive Aspergillosis Associated With Sorafenib Therapy for Hepatocellular Carcinoma.
Topics: Adenine; Aspergillosis; Carcinoma, Hepatocellular; Humans; Invasive Fungal Infections; Liver Neoplas | 2018 |
Serious Infections in Patients Receiving Ibrutinib for Treatment of Lymphoid Cancer.
Topics: Adenine; Adult; Aged; Aged, 80 and over; Bacterial Infections; Electronic Health Records; Female; Hu | 2018 |
Isavuconazole for the treatment of invasive fungal disease in patients receiving ibrutinib.
Topics: Adenine; Antifungal Agents; Humans; Invasive Fungal Infections; Nitriles; Piperidines; Pyrazoles; Py | 2019 |
Low risk of Pneumocystis jirovecii pneumonia and invasive aspergillosis in patients with Waldenström macroglobulinaemia on ibrutinib.
Topics: Adenine; Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Female; Humans; Invasive Fungal Infe | 2019 |
Disseminated mucormycosis due to Lichtheimia corymbifera during ibrutinib treatment for relapsed chronic lymphocytic leukaemia: a case report.
Topics: Abdomen; Adenine; Aged; Fatal Outcome; Humans; Invasive Fungal Infections; Leukemia, Lymphocytic, Ch | 2019 |